A company from Iasi is preparing to enter the billionaires’ club – Ziarul de Iasi

By 2030, Antibiotice Iasi plans to double its turnover compared to the period 2021-2022. This means about 1 billion lei, according to calculations cited by zf.ro.

Beyond the numbers, the strategy goes even further and is measured in new production units, some as a premiere for the local market, new products in the portfolio, but also a team with the same people, adapted to the novelties on the platform.

“Practically, the business doubles and we know exactly how much we need to achieve from this progressive growth, adapting to the specifics of each year. Thus, we have a clear projection of how much we need to grow each year. And it’s normal for it to be like that”, emphasizes the director of the company, Ioan Nani.

Human resources are important for any business, and in the field of drug production, the need for qualified people is critical. That’s why Antibiotice prepares and integrates both young people through internship programs, as well as current employees, in order to be flexible and adapt to the way the company will look in five to ten years.